Evaluating protein quality of fava bean and honey chlorella in healthy adults
Protein Quality of Fava Bean Meat Analogue and Honey Chlorella Ingested as Mixed Meals in Healthy Volunteers
This study tests how well the body digests and absorbs protein from fava beans and honey chlorella in healthy adults.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 16 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement Academic / other |
| Locations | 1 site (Bobigny) |
| Trial ID | NCT06436937 on ClinicalTrials.gov |
What this trial studies
This project aims to assess the protein quality of alternative protein sources, specifically honey chlorella and faba bean meat analogue, in healthy individuals. Participants will consume meals containing these proteins, which are intrinsically labeled with 15N to track their digestibility and nitrogen retention. The study will utilize naso-ileal tubes to collect ileal digesta for analysis over an 8-hour postprandial period. The goal is to determine the nutritional value of these protein sources in terms of digestibility and amino acid absorption.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18 to 30 with a BMI between 18 and 30.
Not a fit: Patients with food allergies, chronic diseases, or those who engage in excessive exercise may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the nutritional benefits of alternative protein sources, potentially improving dietary options for individuals seeking plant-based proteins.
How similar studies have performed: While studies on protein digestibility are common, the specific use of 15N labeling in assessing alternative protein sources like honey chlorella and faba bean is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18\<BMI\<30 * Good health (WHO=0) * For woman: use of birth control Exclusion Criteria: * food allergy * allergy against latex * pregnant women * Positive serology for AgHBS, AcHbc, HCV, HIV * Anemia * Excessive alcohool consumption * Hypertension, diabetes, digestive, hepatic or renal diseases, cardiac disease * Exercice\>7h/week * Blood donation within 3 months before the study * Participation to another clinical study within 3 months before the study
Where this trial is running
Bobigny
- Research Center on Volunteers — Bobigny, France (Recruiting)
Study contacts
- Principal investigator: Robert Benamouzig, MD, PhD — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Claire Gaudichon, PhD, Prof
- Email: claire.gaudichon@agroparistech.fr
- Phone: 33189100852
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.